|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2010-3-18
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Prospective, multicenter, randomized, double-masked trials have shown latanoprost instilled once daily to be at least as effective as and generally superior to timolol administered twice daily and to be as effective as other frequently prescribed prostaglandin analogues. This study prospectively assessed the efficacy of latanoprost monotherapy in a large cohort of treatment-naive patients with a broad range of baseline intraocular pressure (IOP) levels treated in actual clinical practice settings.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-10887918,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-11024415,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-11713061,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-12049574,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-12204703,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-12365904,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-12523884,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-12719078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-12809964,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-12948052,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-14697910,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-15090413,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-15218396,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-15364049,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-15640920,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-15684807,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-15885795,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-16226511,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-16458092,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-17628686,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-17686450,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-18303382,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-18465724,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-19217951,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-19284321,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-19427617,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-2369237,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-3812621,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-8484454,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-8628543,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-8628544,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-8764799,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-9098273,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20181282-9780093
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1471-2415
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4
|
|
pubmed:dateRevised |
2010-9-30
|
|
pubmed:meshHeading |
pubmed-meshheading:20181282-Aged,
pubmed-meshheading:20181282-Antihypertensive Agents,
pubmed-meshheading:20181282-Conjunctiva,
pubmed-meshheading:20181282-Drug Administration Schedule,
pubmed-meshheading:20181282-Eye,
pubmed-meshheading:20181282-Female,
pubmed-meshheading:20181282-Glaucoma, Open-Angle,
pubmed-meshheading:20181282-Humans,
pubmed-meshheading:20181282-Hyperemia,
pubmed-meshheading:20181282-Instillation, Drug,
pubmed-meshheading:20181282-Intraocular Pressure,
pubmed-meshheading:20181282-Male,
pubmed-meshheading:20181282-Middle Aged,
pubmed-meshheading:20181282-Ocular Hypertension,
pubmed-meshheading:20181282-Pain,
pubmed-meshheading:20181282-Prognosis,
pubmed-meshheading:20181282-Prostaglandins F, Synthetic,
pubmed-meshheading:20181282-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure.
|
|
pubmed:affiliation |
Ophthalmology Department, Hôpital Edouard Herriot, 5, Place d'Arsonval, 690437 Lyon Cedex 03, France. philippe.denis@chu-lyon.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase IV
|
